Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AGIO Agios Pharmaceuticals, Inc.

休市中 04-26 16:00:00 EDT

31.49

-0.18

-0.57%

盘后31.49

+0.000.00%

17:05 EDT

最高32.01	最低31.31	成交量41.93万
今开31.70	昨收31.67	日振幅2.21%
总市值17.70亿	流通市值14.99亿	总股本5,619万
成交额1,322万	换手率0.88%	流通股本4,760万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":31.49,"timestamp":1714161600000,"preClose":31.67,"halted":0,"volume":419310,"hourTrading":{"tag":"盘后","latestPrice":31.49,"preClose":31.49,"latestTime":"17:05 EDT","volume":15801,"amount":497573.23,"timestamp":1714165531956},"delay":0,"floatShares":47600901,"shares":56194847,"eps":-6.326659,"marketStatus":"休市中","marketStatusCode":7,"change":-0.18,"latestTime":"04-26 16:00:00 EDT","open":31.7,"high":32.01,"low":31.31,"amount":13218307.4745,"amplitude":0.022103,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.326659,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":1374638400000,"adjPreClose":31.67,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":31.49,"preClose":31.49,"latestTime":"17:05 EDT","volume":15801,"amount":497573.23,"timestamp":1714165531956},"volumeRatio":0.4991975883785292},"requestUrl":"/m/hq/s/AGIO/","defaultTab":"news","newsList":[{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":"    路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻             * Biomarin Pharmaceutical Inc   ：Piper Sandler将目标价从115美元下调至107美元             * Intuit Inc   ：Susquehanna将目标价从700美元上调至775美元             * Penumbra Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412997396","title":"Agios Pharmaceuticals Inc2023财年实现净利润-3.52亿美元，同比减少51.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412997396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412997396?lang=zh_cn&edition=full","pubTime":"2024-02-19 00:19","pubTimestamp":1708273170,"startTime":"0","endTime":"0","summary":"12月31日，Agios Pharmaceuticals Inc公布财报，公告显示公司2023财年净利润为-3.52亿美元，同比减少51.72%；其中营业收入为26.82百万美元，同比增加88.34%，每股基本收益为-6.33美元。机构评级：截至2023年12月31日，当前有6家机构对Agios Pharmaceuticals Inc目标价做出预测，其中目标均价为40.83美元，其中最低目标价为29.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219001938879e4558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240219001938879e4558&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Bloom Energy Corp   ：KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元  * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411251632","title":"美国研究综述-英伟达、Albemarle、Dropbox","url":"https://stock-news.laohu8.com/highlight/detail?id=2411251632","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411251632?lang=zh_cn&edition=full","pubTime":"2024-02-16 17:25","pubTimestamp":1708075529,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻  * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Deere & Co   ：大和资本市场将目标价从425美元下调至400美元  * Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411635884","title":"美国研究综述-阿尔伯马尔、Dropbox、泰勒科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2411635884","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411635884?lang=zh_cn&edition=full","pubTime":"2024-02-16 15:19","pubTimestamp":1708067998,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Tyler Technologies。要闻  * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Deere & Co   ：大和资本市场将目标价从425美元下调至400美元  * Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元              * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.0664},{"period":"1month","weight":0.0814},{"period":"3month","weight":0.3469},{"period":"6month","weight":0.5769},{"period":"1year","weight":0.4108},{"period":"ytd","weight":0.414}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于通过细胞代谢领域的领导地位改变患者的生活，目标是为罕见病创造差异化药物，重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.042769},{"month":2,"riseRate":0.636364,"avgChangeRate":0.059258},{"month":3,"riseRate":0.545455,"avgChangeRate":0.003251},{"month":4,"riseRate":0.545455,"avgChangeRate":0.003003},{"month":5,"riseRate":0.5,"avgChangeRate":0.042804},{"month":6,"riseRate":0.6,"avgChangeRate":0.032699},{"month":7,"riseRate":0.3,"avgChangeRate":-0.034242},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.049224},{"month":9,"riseRate":0.545455,"avgChangeRate":0.047807},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.015381},{"month":11,"riseRate":0.636364,"avgChangeRate":0.038309},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.013921}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况